Invitrogen™ Human DR6 Synthetic Peptide

Ref.: BL-RE-175506Manufacturer ref.: PEP-0055 50 μg
€149.00 excl. VAT

DR6 Synthetic Peptide, PEP-0055, from Invitrogen.

Gene ID (Enter)
27242
Species
Human
Purification method
Purified
Accession number
O75509
Common name
Human DR6
Brand
Invitrogen

DR6 Synthetic Peptide, PEP-0055, from Invitrogen.

DR6 Synthetic Peptide, PEP-0055, from Invitrogen.

DR6 is widely expressed in human tissues and cell lines. The ligand for DR6 has not been identified. Apoptosis is induced by certain cytokines including TNF and Fas ligand of the TNF family through their death domain containing receptors, TNF-R1 and Fas. Several novel death receptors including DR3, DR4, and DR5 were recently identified. A new death domain containing receptor in the TNFR family was cloned recently and termed DR6 for death receptor-6. Like TNF-R1, DR6 interacts with death domain containing adapter molecule TRADD. Overexpression of DR6 induces apoptosis and activates NF-kappa-B and JNK.

Species

Species: Human.

Conservation

Storage: -20°C.

Formulation

Concentration: 200 μg/mL.

Regulatory status

Research only (RUO).

Packaging

Packaging: 50 μg.

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)15286279
Specifications
Gene ID (Enter)27242
SpeciesHuman
Purification methodPurified
Accession numberO75509
Common nameHuman DR6
Concentration200 μg/mL
DescriptionSynthetic Peptide
FormatLiquid
FormulaPBS with 0.1% BSA and 0.02% sodium azide; pH 7.2
For use with (application)Blocking Assay, Control
Gene symbol(s)TNFRSF21
LyophilizedNo
Product typePeptide
Quantity50 μg
Regulatory statusRUO - research use only
Storage and shipping
Content and storage-20°C
Conservative0.02% sodium azide
Storage stampPBS

Origin and customs

Manufacturer ref.PEP-0055
Country of originUnited States
HS customs code3824 99 96 00
A question or a specific configuration?
Contact us for a quote.